| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $397.6M | -1.6% |
| R&D Expense | $36.7M | +24.0% |
| SG&A Expense | $57.3M | -1.6% |
| Operating Income | $124.2M | -12.8% |
| Interest Expense | $33.1M | -15.0% |
| Pre-tax Income | $97.6M | -7.7% |
| Income Tax | -$48.1M | -452.0% |
| Net Income | $145.7M | +58.2% |
| EPS (Basic) | $1.12 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $139.0M | -7.6% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $48.2M | -11.0% |
| Inventory | $63.2M | +27.7% |
| Current Assets | $314.6M | -2.9% |
| Total Assets | $781.5M | +2.9% |
| Current Liabilities | $72.0M | -14.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $16.3M | -63.0% |
| +49.3% |
| EPS (Diluted) | $1.09 | +53.5% |
| Long-term Debt |
| $587.5M |
| -17.4% |
| Total Liabilities | $740.8M | -14.0% |
| Stockholders' Equity | $40.7M | +140.0% |